Indivior Pharmaceuticals, Inc.

DB:E7P Stock Report

Market Cap: €4.2b

Indivior Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:E7P Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Mar 26Buy€217Barbara RyanIndividual8€27.17
09 Mar 26Buy€871Barbara RyanIndividual31€28.09
06 Mar 26Buy€25,826Stuart KingsleyIndividual940€27.47
05 Jan 26Buy€53,535David WheadonIndividual1,771€30.23
05 Jan 26Buy€23,427Barbara RyanIndividual775€30.23
05 Jan 26Buy€23,427Daniel NinivaggiIndividual775€30.23
05 Jan 26Buy€23,427Mark StejbachIndividual775€30.23
05 Jan 26Buy€23,427Keith HumphreysIndividual775€30.23
19 Dec 25Sell€28,989,785Two Seas Capital LPCompany950,000€31.02
12 Dec 25Buy€3,045,543Two Seas Capital LPCompany100,000€30.46
10 Dec 25Sell€0Two Seas Capital LPCompany2,867,262€31.90
03 Dec 25Buy€18,505,729Two Seas Capital LPCompany674,964€29.33
13 Nov 25Sell€49,617,659Brookfield CorporationCompany1,946,969€26.78
03 Nov 25Sell€39,717,418Two Seas Capital LPCompany1,575,000€27.15
27 Oct 25Buy€10,119,607Two Seas Capital LPCompany500,000€21.29
03 Sep 25Sell€31,391,059Two Seas Capital LPCompany1,600,000€21.15
29 Aug 25Buy€5,295,909Two Seas Capital LPCompany266,844€20.95
28 Jul 25Buy€15,288,482Two Seas Capital LPCompany1,088,309€14.74
25 Jul 25Sell€18,455,468Two Seas Capital LPCompany1,334,060€14.59
11 Jul 25Buy€12,226,130Two Seas Capital LPCompany1,295,000€9.79
10 Jul 25Sell€3,595,263Two Seas Capital LPCompany273,118€13.24

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of E7P?
Owner TypeNumber of SharesOwnership Percentage
State or Government39,0300.0301%
Individual Insiders1,955,4251.51%
VC/PE Firms6,984,1025.38%
Institutions120,841,37593.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.2%
BlackRock, Inc.
18,542,220€645.2m1.71%0.01%
6.47%
Vanguard Portfolio Management, LLC
7,891,819€274.6m0%0.01%
5.73%
Brookfield Corporation
6,984,102€243.0m-1.75%0.31%
4.58%
Vanguard Capital Management, LLC
5,586,576€194.4m0%no data
4.02%
State Street Global Advisors, Inc.
4,903,993€170.6m5.25%0.01%
3.89%
Two Seas Capital LP
4,746,510€165.2m-7.1%7.5%
3.77%
Millennium Management LLC
4,595,535€159.9m96.6%0.11%
3.72%
Fuller & Thaler Asset Management, Inc.
4,529,583€157.6m-28.9%0.52%
3.54%
Madison Avenue Partners, LP
4,315,162€150.2m-31.3%4.65%
2.93%
Citadel Advisors LLC
3,574,044€124.4m16.7%0.09%
2.73%
Morgan Stanley
3,330,794€115.9m-20.4%0.01%
2.54%
Deerfield Management Company, L.P.
3,097,790€107.8m-8.7%1.38%
2.4%
Geode Capital Management, LLC
2,925,688€101.8m3.1%0.01%
2.25%
Mangrove Partners IM, LLC
2,742,434€95.4m-0.13%8.15%
1.91%
Arrowstreet Capital, Limited Partnership
2,323,264€80.8m36.2%0.04%
1.8%
UBS Asset Management AG
2,193,714€76.3m122%0.01%
1.78%
The Goldman Sachs Group, Inc.
2,174,046€75.7m-27.2%0.02%
1.64%
Newtyn Management, LLC
2,000,000€69.6m-21.1%6.91%
1.54%
Driehaus Capital Management LLC
1,880,039€65.4m-6.01%0.33%
1.51%
Healthcare of Ontario Pension Plan Trust Fund
1,835,100€63.9m-20.4%0.11%
1.19%
Invesco Capital Management LLC
1,449,901€50.5m667%0.01%
1.14%
Acadian Asset Management LLC
1,391,612€48.4m-54.9%0.06%
1.09%
Dimensional Fund Advisors LP
1,332,128€46.4m19.1%0.01%
1.04%
Soleus Capital Management, L.P.
1,274,000€44.3m1,170%1.56%
0.98%
Federated Hermes, Inc.
1,200,137€41.8m80.3%0.07%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/05 07:49
End of Day Share Price 2026/07/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Indivior Pharmaceuticals, Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Glen SantangeloBarclays
Graham Glyn ParryBofA Global Research
Chase KnickerbockerCraig-Hallum Capital Group LLC